Every day, MIPS researchers dedicate their time to researching and designing better medicines. We are Australia's largest, most experienced and successful group of pharmaceutical scientists. Over 160 scientists and 120 PhD students undertake basic and translational drug discovery, drug delivery and drug development research in new, state-of-the-art laboratories on Monash's Parkville campus.
Our internationally recognised institute strives to conduct the most insightful science. We focus on oncology, infectious disease, pain and inflammation, neuroscience and metabolic disease. Our researchers are leaders in their fields. Their brilliance and dedication ensures that better medicines of world significance are discovered, researched and designed right here in Australia.
Cancer Therapeutics CRC (CTx) is in the business of finding cures for cancer. It is a collaborative partnership of leading Research Institutes, Universities and biotechnology companies that translates Australia's innovative research discoveries into new cancer drugs ready for clinical development.
The company's research and development capabilities span the full range of technologies and expertise required to discover novel small molecule cancer drugs and develop them to the clinical candidate stage. Our collaborative model allows us to integrate experts in cancer target biology into our project teams. Our business model allows us routes to commercialisation through our internal commercial partners or by partnering with international pharmaceutical or biotechnology companies.